SirT2 is a Histone Deacetylase with Preference for Histone H4 Lys 16 During Mitosis
Overview
Authors
Affiliations
The mammalian cytoplasmic protein SirT2 is a member of the Sir2 family of NAD+-dependent protein deacetylases involved in caloric restriction-dependent life span extension. We found that SirT2 and its yeast counterpart Hst2 have a strong preference for histone H4K16Ac in their deacetylation activity in vitro and in vivo. We have pinpointed the decrease in global levels of H4K16Ac during the mammalian cell cycle to the G2/M transition that coincides with SirT2 localization on chromatin. Mouse embryonic fibroblasts (MEFs) deficient for SirT2 show higher levels of H4K16Ac in mitosis, in contrast to the normal levels exhibited by SirT1-deficient MEFs. The enzymatic conversion of H4K16Ac to its deacetylated form may be pivotal to the formation of condensed chromatin. Thus, SirT2 is a major contributor to this enzymatic conversion at the time in the cell's life cycle when condensed chromatin must be generated anew.
SIRT2 and ALDH1A1 as critical enzymes for astrocytic GABA production in Alzheimer's disease.
Bhalla M, Joo J, Kim D, Shin J, Park Y, Ju Y Mol Neurodegener. 2025; 20(1):6.
PMID: 39815261 PMC: 11734448. DOI: 10.1186/s13024-024-00788-8.
Jessop E, Young N, Garcia-Del-Valle B, Crusher J, Obara B, Karakesisoglou I Cells. 2024; 13(23).
PMID: 39682770 PMC: 11639776. DOI: 10.3390/cells13232023.
Epigenetics-targeted drugs: current paradigms and future challenges.
Dai W, Qiao X, Fang Y, Guo R, Bai P, Liu S Signal Transduct Target Ther. 2024; 9(1):332.
PMID: 39592582 PMC: 11627502. DOI: 10.1038/s41392-024-02039-0.
Interplay Between the Circadian Clock and Sirtuins.
Zhuang Y, Zhang Y, Liu C, Zhong Y Int J Mol Sci. 2024; 25(21).
PMID: 39519022 PMC: 11545976. DOI: 10.3390/ijms252111469.
NAD enhancers as therapeutic agents in the cardiorenal axis.
Marin-Blazquez M, Rovira J, Ramirez-Bajo M, Zapata-Perez R, Rabadan-Ros R Cell Commun Signal. 2024; 22(1):537.
PMID: 39516787 PMC: 11546376. DOI: 10.1186/s12964-024-01903-4.